Peter Bader
Children's Hospital of the JW Goethe University
Frankfurt
Germany
Name/email consistency: high
- Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Bader, P., Kreyenberg, H., Henze, G.H., Eckert, C., Reising, M., Willasch, A., Barth, A., Borkhardt, A., Peters, C., Handgretinger, R., Sykora, K.W., Holter, W., Kabisch, H., Klingebiel, T., von Stackelberg, A. J. Clin. Oncol. (2009)
- Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. Bader, P., Niemeyer, C., Willasch, A., Kreyenberg, H., Strahm, B., Kremens, B., Gruhn, B., Dilloo, D., Vormoor, J., Lang, P., Niethammer, D., Klingebiel, T., Beck, J.F. Br. J. Haematol. (2005)